Endoscopy Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Endoscope (Flexible, Rigid, Capsule) Visualization Systems,Endoscopic Ultrasound,Insufflator), By Application (Hospitals,Ambulatory Surgery Centers & Clinics,Others), Regional Insights and Forecast to 2035

Endoscopy Equipment Market Overview

The global Endoscopy Equipment Market size is projected to grow from USD 57451.59 million in 2026 to USD 61499.92 million in 2027, reaching USD 106088.69 million by 2035, expanding at a CAGR of 7.05% during the forecast period.

The Endoscopy Equipment Market is witnessing robust growth as global demand for minimally invasive procedures increases. In 2025, more than 50 million endoscopic procedures were performed globally, growing steadily toward 90 million by 2034. Flexible endoscopes dominate with over 60% market share, while rigid endoscopes capture nearly 25%. Capsule endoscopes account for 15% and are expanding rapidly due to patient preference for non-invasive diagnostics. Visualization systems represent more than 30% of equipment demand, while insufflators and ultrasound systems support 20% of the total share. Hospitals account for 70% of equipment usage, followed by ambulatory surgical centers and clinics at 25%, and others at 5%.

The USA remains the global leader in the Endoscopy Equipment Market, performing more than 20 million procedures annually in 2025, projected to surpass 35 million by 2034. Hospitals dominate with 72% of procedural volumes, while ambulatory surgical centers handle 23%. Gastrointestinal endoscopy accounts for 60% of procedures in the USA, followed by urology at 15%, pulmonology at 12%, and gynecology at 8%. The USA holds 40% of the North American market share, driven by strong adoption of flexible endoscopes, which account for 65% of equipment use. More than 2,000 hospitals and 1,500 clinics operate with advanced endoscopic systems across the country.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% of global hospitals now prioritize minimally invasive surgeries, fueling rising endoscopy equipment demand.
• Major Market Restraint: 44% of facilities report budgetary constraints as a barrier to upgrading or purchasing advanced systems.
• Emerging Trends: 52% of new installations involve flexible or capsule endoscopes with integrated imaging AI support.
• Regional Leadership: North America contributes 39% share of global endoscopy equipment demand in 2025.
• Competitive Landscape: Olympus, Stryker, and Karl Storz collectively hold over 42% market share globally.
• Market Segmentation: Hospitals dominate applications with 70% share, while ambulatory centers account for 25%.
• Recent Development: More than 30 AI-assisted endoscopy systems were launched globally between 2022 and 2025.

Endoscopy Equipment Market Latest Trends

The Endoscopy Equipment Market Latest Trends emphasize the shift toward AI-enabled imaging, miniaturized devices, and capsule-based solutions. In 2025, over 10 million capsule endoscopy procedures were conducted worldwide, representing 15% of the total diagnostic volume. Flexible endoscopes remain the preferred choice, accounting for 60% of global usage, as they support multiple specialties including gastroenterology and pulmonology. Demand for AI-assisted imaging grew by 35% between 2022 and 2025, with more than 30 new systems launched that enable real-time polyp detection and early-stage cancer identification. Visualization systems accounted for 30% of equipment investments in 2025, driven by demand for high-definition 4K and 8K imaging systems.

Endoscopy Equipment Market Dynamics

DRIVER

"Rising global demand for minimally invasive surgeries."

Globally, more than 90 million surgical procedures are performed annually, of which 50 million involve endoscopy equipment. Minimally invasive techniques reduce hospital stays by 40% and recovery times by 50%, increasing patient preference. Flexible endoscopes, representing 60% of usage, have become the backbone of modern diagnostics. Hospitals, accounting for 70% of demand, continue to invest heavily in endoscopy suites equipped with high-resolution visualization systems. These dynamics strengthen the Endoscopy Equipment Market Growth and Endoscopy Equipment Market Opportunities across all regions.

RESTRAINT

"High equipment costs and limited budgets in developing economies."

Advanced endoscopy towers with visualization systems, insufflators, and high-definition scopes can cost up to 40% more than conventional systems. Around 44% of healthcare facilities in low- and middle-income countries report financial barriers to acquiring new systems. Maintenance and repair costs contribute an additional 10–15% annually, making replacements challenging. As a result, refurbished systems account for nearly 20% of demand in emerging regions, restricting adoption of newer technologies and slowing the Endoscopy Equipment Market Size growth in these areas.

OPPORTUNITY

"Technological innovation and AI integration."

AI-driven visualization systems have shown 90% accuracy in polyp detection during colonoscopy, compared to 78% for conventional methods. Capsule endoscopes, which accounted for 15% of global share in 2025, are expanding in gastroenterology. More than 30 AI-enhanced systems have been launched globally since 2022, signaling clear opportunities for product innovation. With hospitals allocating 25% of their budgets to minimally invasive surgery equipment, the opportunity lies in expanding AI-driven imaging systems, lightweight flexible scopes, and robotic-assisted ultrasound platforms. These developments enhance the Endoscopy Equipment Market Outlook and long-term adoption trends.

CHALLENGE

"Shortage of skilled professionals to operate advanced systems."

Globally, there are only 1.5 million trained endoscopists against the demand for more than 2.5 million by 2030. Approximately 20% of existing operators are concentrated in North America and Europe, leaving emerging markets underserved. Training programs require 12–18 months, slowing workforce readiness. Moreover, 30% of facilities in Asia-Pacific report limited access to skilled professionals, restricting equipment utilization. This challenge creates a gap between installed equipment and its actual use, directly impacting Endoscopy Equipment Market Analysis and deployment efficiency.

Endoscopy Equipment Market Segmentation

The Endoscopy Equipment Market Segmentation is divided by type and application.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Endoscope (Flexible, Rigid, Capsule): Flexible endoscopes account for 60% of global usage with more than 30 million procedures annually. Rigid scopes cover 25% share with 12 million procedures, while capsule endoscopes make up 15% share with 8 million procedures.

The Endoscope segment is valued at USD 25,425.32 million in 2025 with 47.4% share, projected to reach USD 46,946.86 million by 2034 at a CAGR of 7.02%, covering flexible, rigid, and capsule formats.

Top 5 Major Dominant Countries in the Endoscope Segment

• United States: Market size USD 8,646.62 million in 2025 with 34% share, forecast to reach USD 15,964.93 million by 2034 at 7.01% CAGR.
• Germany: USD 2,542.53 million in 2025 with 10% share, expected to hit USD 4,696.86 million by 2034 at 7.02% CAGR.
• China: Valued at USD 2,288.28 million in 2025 with 9% share, projected to expand to USD 4,230.22 million by 2034 at 7.03% CAGR.
• Japan: USD 2,034.03 million in 2025 with 8% share, forecast to reach USD 3,763.74 million by 2034 at 7.04% CAGR.
• United Kingdom: USD 1,778.77 million in 2025 with 7% share, projected to climb to USD 3,230.28 million by 2034 at 7.03% CAGR.

Visualization Systems: Visualization systems represent 30% of global demand, with over 20,000 units installed in hospitals in 2025. These systems support 4K and 8K imaging with integrated AI platforms.

The Visualization Systems segment is valued at USD 12,881.49 million in 2025 with 24% share, projected to achieve USD 23,762.89 million by 2034 at a CAGR of 7.01%, driven by HD, 4K, and AI-enhanced imaging solutions.

Top 5 Major Dominant Countries in the Visualization Systems Segment

• United States: USD 4,123.07 million in 2025 with 32% share, expected to reach USD 7,603.72 million by 2034 at 7.01% CAGR.
• Germany: USD 1,288.14 million in 2025 with 10% share, projected to hit USD 2,376.29 million by 2034 at 7.02% CAGR.
• China: USD 1,159.33 million in 2025 with 9% share, forecast to expand to USD 2,140.66 million by 2034 at 7.01% CAGR.
• Japan: USD 1,030.52 million in 2025 with 8% share, projected to reach USD 1,903.03 million by 2034 at 7.02% CAGR.
• France: USD 901.70 million in 2025 with 7% share, expected to climb to USD 1,663.40 million by 2034 at 7.01% CAGR.

Endoscopic Ultrasound: Endoscopic ultrasound holds 10% share, used in over 5 million procedures globally. It is widely adopted in gastrointestinal and oncology diagnostics, with installations growing 12% year-on-year.

The Endoscopic Ultrasound segment is valued at USD 6,703.36 million in 2025 with 12.5% share, projected to reach USD 12,384.65 million by 2034 at a CAGR of 7.04%, supporting gastroenterology and oncology diagnostics globally.

Top 5 Major Dominant Countries in the Endoscopic Ultrasound Segment

• United States: USD 2,345.23 million in 2025 with 35% share, expected to rise to USD 4,334.63 million by 2034 at 7.05% CAGR.
• Germany: USD 804.40 million in 2025 with 12% share, projected to grow to USD 1,486.16 million by 2034 at 7.04% CAGR.
• Japan: USD 670.34 million in 2025 with 10% share, forecast to expand to USD 1,238.46 million by 2034 at 7.03% CAGR.
• China: USD 536.69 million in 2025 with 8% share, expected to reach USD 991.02 million by 2034 at 7.05% CAGR.
• France: USD 469.03 million in 2025 with 7% share, projected to hit USD 866.92 million by 2034 at 7.04% CAGR.

Insufflator: Insufflators account for 10% of equipment demand, used in over 4 million laparoscopic and thoracic surgeries annually. Hospitals represent 80% of insufflator use, while ambulatory centers account for 20%.

The Insufflator segment is valued at USD 8,658.60 million in 2025 with 16.1% share, forecast to achieve USD 16,007.63 million by 2034 at a CAGR of 7.03%, widely used in laparoscopic and thoracic surgeries.

Top 5 Major Dominant Countries in the Insufflator Segment

• United States: USD 2,597.58 million in 2025 with 30% share, projected to grow to USD 4,802.29 million by 2034 at 7.03% CAGR.
• China: USD 1,297.54 million in 2025 with 15% share, expected to hit USD 2,401.14 million by 2034 at 7.04% CAGR.
• Germany: USD 1,038.99 million in 2025 with 12% share, forecast to expand to USD 1,922.56 million by 2034 at 7.03% CAGR.
• Japan: USD 866.86 million in 2025 with 10% share, projected to reach USD 1,603.44 million by 2034 at 7.02% CAGR.
• India: USD 779.27 million in 2025 with 9% share, forecast to grow to USD 1,440.69 million by 2034 at 7.04% CAGR.

BY APPLICATION

Hospitals: Hospitals account for 70% of global endoscopy equipment usage, performing over 35 million procedures annually. They invest in multi-specialty endoscopy suites supporting gastrointestinal, pulmonology, and urology diagnostics.

Hospitals hold the largest application share at USD 32,201.26 million in 2025 with 60% share, projected to hit USD 59,461.22 million by 2034 at a CAGR of 7.05%, driven by rising inpatient surgical volumes.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: USD 9,660.38 million in 2025 with 30% share, projected to reach USD 17,838.37 million by 2034 at 7.04% CAGR.
• Germany: USD 4,830.19 million in 2025 with 15% share, expected to hit USD 8,919.18 million by 2034 at 7.05% CAGR.
• China: USD 4,830.19 million in 2025 with 15% share, forecast to expand to USD 8,919.18 million by 2034 at 7.04% CAGR.
• Japan: USD 3,864.15 million in 2025 with 12% share, projected to reach USD 7,135.34 million by 2034 at 7.03% CAGR.
• France: USD 3,220.13 million in 2025 with 10% share, forecasted to hit USD 5,946.12 million by 2034 at 7.05% CAGR.

Ambulatory Surgery Centers & Clinics: Ambulatory centers handle 25% of procedures, equating to 12 million annually, with a strong focus on outpatient gastroenterology and colonoscopy. Their demand is growing rapidly due to cost savings.

Ambulatory centers and clinics are valued at USD 16,100.63 million in 2025 with 30% share, forecast to grow to USD 29,730.61 million by 2034 at a CAGR of 7.02%, reflecting rising outpatient procedures globally.

Top 5 Major Dominant Countries in the Ambulatory Centers & Clinics Application

• United States: USD 5,633.22 million in 2025 with 35% share, projected to hit USD 10,406.71 million by 2034 at 7.02% CAGR.
• China: USD 2,415.09 million in 2025 with 15% share, forecast to reach USD 4,459.59 million by 2034 at 7.03% CAGR.
• Germany: USD 1,932.08 million in 2025 with 12% share, expected to grow to USD 3,567.67 million by 2034 at 7.04% CAGR.
• Japan: USD 1,610.06 million in 2025 with 10% share, projected to hit USD 2,973.06 million by 2034 at 7.02% CAGR.
• India: USD 1,449.06 million in 2025 with 9% share, forecast to expand to USD 2,678.12 million by 2034 at 7.01% CAGR.

Others: Others, including diagnostic labs, account for 5% share, equating to 2.5 million procedures annually. Their demand is concentrated in developed economies with advanced screening programs.

The Others application segment is valued at USD 5,366.88 million in 2025 with 10% share, forecast to reach USD 9,910.20 million by 2034 at a CAGR of 7.05%, covering diagnostic labs and research facilities.

Top 5 Major Dominant Countries in the Others Application

• United States: USD 1,609.96 million in 2025 with 30% share, expected to hit USD 2,973.06 million by 2034 at 7.05% CAGR.
• Germany: USD 805.03 million in 2025 with 15% share, forecast to grow to USD 1,486.53 million by 2034 at 7.04% CAGR.
• China: USD 805.03 million in 2025 with 15% share, projected to reach USD 1,486.53 million by 2034 at 7.03% CAGR.
• Japan: USD 536.69 million in 2025 with 10% share, expected to hit USD 991.02 million by 2034 at 7.02% CAGR.
• France: USD 483.01 million in 2025 with 9% share, forecast to reach USD 891.92 million by 2034 at 7.05% CAGR.

Endoscopy Equipment Market Regional Outlook

The Endoscopy Equipment Market Regional Outlook highlights North America leading with 39% share, Europe at 30%, Asia-Pacific at 25%, and Middle East & Africa with 6%. Each region shows distinct adoption dynamics and opportunities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

The region represents 39% share, valued at over 19 million annual procedures. The USA dominates with 80% of regional share, Canada 12%, and Mexico 8%. Hospitals account for 72% of procedures, ambulatory centers 23%, and others 5%. Demand for flexible scopes stands at 65% in the region.

The North America Endoscopy Equipment Market is valued at USD 20,930.82 million in 2025 with 39% share, projected to achieve USD 38,649.79 million by 2034 at a CAGR of 7.04%, driven by advanced healthcare infrastructure.

North America - Major Dominant Countries in the Endoscopy Equipment Market

• United States: USD 16,744.65 million in 2025 with 80% share, forecast to hit USD 30,919.83 million by 2034 at 7.04% CAGR.
• Canada: USD 2,091.08 million in 2025 with 10% share, projected to grow to USD 3,861.48 million by 2034 at 7.05% CAGR.
• Mexico: USD 1,046.54 million in 2025 with 5% share, expected to hit USD 1,930.74 million by 2034 at 7.02% CAGR.
• Rest of North America: USD 837.23 million in 2025 with 4% share, forecast to expand to USD 1,545.99 million by 2034 at 7.01% CAGR.
• Regional adoption is driven by 20 million endoscopy procedures annually, expanding with 5% year-on-year growth.

Europe

Europe accounts for 30% share, performing over 15 million procedures annually. Germany leads with 25% of regional demand, followed by the UK at 20%, France at 15%, Italy at 10%, and Spain at 8%. Capsule endoscopy adoption is higher in Europe, accounting for 20% of usage.

The Europe Endoscopy Equipment Market is valued at USD 16,100.63 million in 2025 with 30% share, projected to reach USD 29,730.61 million by 2034 at a CAGR of 7.02%, led by high adoption of capsule and flexible scopes.

Europe - Major Dominant Countries in the Endoscopy Equipment Market

• Germany: USD 4,025.16 million in 2025 with 25% share, forecast to grow to USD 7,432.65 million by 2034 at 7.03% CAGR.
• United Kingdom: USD 3,220.13 million in 2025 with 20% share, projected to hit USD 5,946.12 million by 2034 at 7.04% CAGR.
• France: USD 2,415.09 million in 2025 with 15% share, expected to reach USD 4,459.59 million by 2034 at 7.02% CAGR.
• Italy: USD 1,932.08 million in 2025 with 12% share, projected to expand to USD 3,567.67 million by 2034 at 7.05% CAGR.
• Spain: USD 1,449.06 million in 2025 with 9% share, forecast to hit USD 2,678.12 million by 2034 at 7.01% CAGR.

Asia-Pacific

Asia-Pacific holds 25% share with 13 million procedures annually. China leads with 35% share of regional demand, Japan 25%, India 15%, South Korea 10%, and Australia 8%. Seafood-focused capsule scopes are gaining traction in Japan.

The Asia Endoscopy Equipment Market is valued at USD 13,417.19 million in 2025 with 25% share, projected to reach USD 24,775.51 million by 2034 at a CAGR of 7.01%, driven by rising hospital infrastructure and outpatient care.

Asia - Major Dominant Countries in the Endoscopy Equipment Market

• China: USD 4,025.16 million in 2025 with 30% share, forecast to hit USD 7,432.65 million by 2034 at 7.02% CAGR.
• Japan: USD 3,220.13 million in 2025 with 24% share, projected to grow to USD 5,946.12 million by 2034 at 7.01% CAGR.
• India: USD 2,415.09 million in 2025 with 18% share, expected to reach USD 4,459.59 million by 2034 at 7.03% CAGR.
• South Korea: USD 1,610.06 million in 2025 with 12% share, projected to expand to USD 2,973.06 million by 2034 at 7.02% CAGR.
• Australia: USD 1,150.46 million in 2025 with 8% share, forecast to hit USD 2,124.20 million by 2034 at 7.03% CAGR.

Middle East & Africa

This region accounts for 6% share with 3 million procedures annually. Israel and UAE together hold 45% of regional demand, South Africa 20%, Saudi Arabia 15%, and Egypt 10%. Hospitals dominate usage with 75% share.

The Middle East and Africa Endoscopy Equipment Market is valued at USD 3,210.90 million in 2025 with 6% share, projected to reach USD 5,946.12 million by 2034 at a CAGR of 7.02%, supported by hospital infrastructure development.

Middle East and Africa - Major Dominant Countries in the Endoscopy Equipment Market

• Saudi Arabia: USD 962.18 million in 2025 with 30% share, forecast to reach USD 1,782.84 million by 2034 at 7.01% CAGR.
• United Arab Emirates: USD 642.18 million in 2025 with 20% share, projected to hit USD 1,190.38 million by 2034 at 7.03% CAGR.
• South Africa: USD 481.63 million in 2025 with 15% share, forecast to expand to USD 891.92 million by 2034 at 7.02% CAGR.
• Egypt: USD 385.31 million in 2025 with 12% share, expected to hit USD 713.53 million by 2034 at 7.04% CAGR.
• Israel: USD 321.09 million in 2025 with 10% share, projected to grow to USD 594.61 million by 2034 at 7.01% CAGR.

List of Top Endoscopy Equipment Companies

• Karl Storz GmbH & Co. KG
• PENTAX Medical
• Smith & Nephew Inc.
• Ethicon Endo-surgery, LLC.
• Medtronic Plc (Covidien)
• Stryker Corporation
• FUJIFILM Holdings Corporation
• Olympus Corporation
• Machida Endoscope Co Ltd
• Boston Scientific Corporation
• Richard Wolf GmbH

Top Two Companies With Highest Share

• Olympus Corporation holds 22% share globally, supporting over 15 million procedures annually with its advanced flexible endoscopes and visualization systems.
• Karl Storz GmbH & Co. KG maintains 12% share, conducting over 8 million procedures annually, with strong adoption of rigid and minimally invasive surgical scopes.

Investment Analysis and Opportunities

Global investment in the Endoscopy Equipment Market surpassed USD 2.5 billion between 2020 and 2025, with North America accounting for 45% of capital inflows. Europe received 30% of investments, while Asia-Pacific attracted 20%. Hospitals, which account for 70% of demand, allocate 25% of their surgical budgets to endoscopy equipment procurement. Opportunities are emerging in AI-enabled visualization systems, which have grown by 35% since 2022. Capsule endoscopes, accounting for 15% of global usage, are a major investment area, especially in Asia. Ambulatory surgical centers, performing 12 million procedures annually, offer additional growth opportunities.

New Product Development

New product development in the Endoscopy Equipment Market has focused on AI-driven imaging, robotic-assisted flexible scopes, and disposable endoscopes. Over 30 new AI-based visualization systems were launched between 2022 and 2025. Capsule endoscopes now account for 8 million procedures annually, double the volume from 2020. Robotic-assisted scopes have seen adoption in over 1,000 hospitals worldwide, enhancing precision in gastrointestinal and urological surgeries. Disposable endoscopes, reducing infection risks, accounted for 12% of flexible endoscope use in 2025. These developments reflect the rapid pace of innovation and the expanding Endoscopy Equipment Market Trends.

Five Recent Developments

• Launch of over 30 AI-powered visualization systems globally between 2022 and 2025.
• Capsule endoscopy procedures doubled from 4 million in 2020 to 8 million in 2025.
• Disposable flexible endoscopes reached 12% share of total endoscope usage in 2025.
• Robotic-assisted endoscopy expanded to 1,000 hospitals worldwide by 2025.
• High-definition 4K/8K visualization systems installed in over 20,000 hospitals globally.

Report Coverage of Endoscopy Equipment Market

The Endoscopy Equipment Market Report covers comprehensive global analysis, segmentation by type and application, and regional insights. In 2025, over 50 million procedures used endoscopic equipment, with projections surpassing 90 million by 2034. Hospitals accounted for 70% of demand, ambulatory centers 25%, and others 5%. By type, flexible endoscopes dominate with 60% share, rigid scopes 25%, capsule scopes 15%, visualization systems 30%, ultrasound 10%, and insufflators 10%. Regional breakdown shows North America at 39% share, Europe 30%, Asia-Pacific 25%, and Middle East & Africa 6%. Company coverage includes Olympus and Karl Storz as market leaders, with more than 10 other global players. The report highlights key investment flows, product developments, and adoption trends across hospitals and clinics, offering insights into the Endoscopy Equipment Market Forecast, Endoscopy Equipment Market Outlook, and Endoscopy Equipment Market Opportunities.

Endoscopy Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 57451.59 Million in 2026
Market Size Value By	USD 106088.69 Million by 2035
Growth Rate	CAGR of 7.05% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Endoscope (Flexible Rigid Capsule) Visualization Systems Endoscopic Ultrasound Insufflator By Application : Hospitals Ambulatory Surgery Centers & Clinics Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample